Radiologist background

ProFound Breast Health Suite

Breast cancer has finally met its match.

Powered by the latest innovations in artificial intelligence (AI), the ProFound Suite offers clinically proven, 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation. With about 2x improvement in clinical performance compared to other AI platforms,3 ProFound offers unrivaled accuracy, as well as multi‐vendor compatibility and unique workflow advantages.

black female doctor portrait transparent background
ProFound Breast Health Suite

Together, we can change more lives.

Backed by science, clinical evidence, and proven patient outcomes, our suite of solutions – Detection, Density, and Risk – shine a spotlight on cancer, exposing its hiding place. Empowering you to personalize breast cancer screening like never before.

smashicons_online_streaming_approved-63-icon-outline
FDA Cleared.
smashicons_online_streaming_approved-63-icon-outline
CE Marked.
smashicons_online_streaming_approved-63-icon-outline
Health Canada Licensed.
Radiologist breast imaging

Detection

Built on one of the largest, most diverse global data sets, our Detection solution offers unrivaled performance and accuracy for both 2D and 3D mammography.4 Scoring cases and lesions so you can identify and focus on areas of most concern. 

radiology studying imaging

Density

The Density Assessment solution simplifies and standardizes breast density reporting and stratification, with accurate and reliable results. By analyzing 2D or 3D mammogram images, it examines the woman’s breast anatomy, delivering clinicians unique and patient-specific breast density assessments, so they can proactively implement a personalized screening plan.

Smiling woman

Risk

Our Risk solution is different, offering up to 2.4x more accuracy than traditional risk models like Tyrer-Cuzick and Gail,1,2 and is personalized based on age and image evidence directly from their mammogram. It’s near-term providing a risk probability score for developing breast cancer in the next 1 or 2 years giving women and care providers more actionable information to design personalized care plans. 

Woman getting a mammogram
Coming Soon

Heart Health

Breast cancer and heart disease are the two leading causes of death among women. Clinical results have found calcifications in arterial vessels within the breast are proven to correlate with calcifications elsewhere in the body, which raises concern for vascular or heart health issues. With our Heart Health solution, the presence and extent of breast arterial calcifications can be identified and measured, helping the care team assess the patient’s risk of heart disease directly from their mammogram.

Imagine a future where a single mammogram informs insights beyond breast health! 

rocky beach
Video

Hear how Dr. Kathy Shilling describes what the ProFound Suite had done for her team.

Experience the ProFound AI difference.  

As the clinically proven industry leader, radiologists using ProFound AI find more cancers more often, more accurately, with fewer unnecessary recalls.

86 -Target- (badge, army, military, war, soldier, retro) Created with Sketch.

Find More Cancer

Positively identify cancers with 2x the clinical performance compared to other AI platforms.3

028 – Limited Time Created with Sketch.

Faster

Cut reading time in half.4

241 – Wait or Calendar (interaction, communication, interface, outline) Created with Sketch.

Earlier

Find or predict cancers 2-3 years earlier.1,2

050 – Target Created with Sketch.

More Accurately

See a 7% reduction in recall rates.4

051 – Stethoscope Created with Sketch.

Industry-leading AUC

Radiologists using ProFound AI experience a 6% increase in cancer detection performance, compared to non-AI readers.4

Breast health scorecard

Meet the ProFound Scorecard.

Automated, integrated, and easy to read – the ProFound Scorecard aids in early cancer detection, breast density assessment, and short-term risk evaluation via actionable mammographic case summary. Giving you the information needed to personalize patient care moving forward. 

Includes: Overall Case Score. Automated Density Assessment Score. Personalized 1-2 year Risk Score.

Breast health doctor

Quality healthcare, reimagined.

AI-powered mammography is playing a role in helping breast imaging centers align to important quality standards and accreditation programs.

  • Mammography Quality Standards Act (MQSA)
  • National Quality Measures for Breast Centers (NQMBC) Program
  • National Accreditation Program for Breast Centers (NAPBC)
  • Institute for Healthcare Improvement Quintuple Aim of Healthcare 
  • American College of Radiology (ACR) Accreditation Program.
smashicons_online_streaming_approved-63-icon-outline

Improved Health Outcomes

smashicons_online_streaming_approved-63-icon-outline

Reduced Healthcare Costs

smashicons_online_streaming_approved-63-icon-outline

Enhanced Patient Experience

smashicons_online_streaming_approved-63-icon-outline

Increased Provider Wellbeing

smashicons_online_streaming_approved-63-icon-outline

Expanded Health Equity

Flexible turnkey solutions and service options designed to meet your unique deployment needs

ProFound Cloud

ProFound Cloud

Connect via your private cloud, AI-marketplace, or directly with iCAD’s native cloud and Success Program.

ProFound On Premises

ProFound On-Premises

Onsite hardware conveniently pre-loaded with iCAD software and tailored Success Program.

Interoperability: 50+ PACS & 94 versions | 2D & 3D OEM manufacturers | AI platform providers & workflow systems

Smiling professional woman
Contact Us

Together, we can create a world where cancer can’t hide.

Ready to experience how ProFound can save lives?

1. Mikael Eriksson et al. A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care. Sci. Transl. Med. 14, eabn3971 (2022). DOI: 10.1126/scitranslmed.abn3971. 2. Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, Förnvik D, Sartor H, Mavaddat N, Easton D, Hall P. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. Radiology. 2020 Nov;297(2):327-333. doi: 10.1148/radiol.2020201620. Epub 2020 Sep 8. PMID: 32897160. 3. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Accessed 1-20-23. FDA 510K submissions K182373 (iCAD), K201019 (Hologic) and K193229 (ScreenPoint). 4. Conant EF, Toledano AY, Periaswamy S, Fotin SV, Go J, Boatsman JE, Hoffmeister JW. Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiol Artif Intell. 2019 Jul 31;1(4):e180096. doi: 10.1148/ryai.2019180096. PMID: 32076660; PMCID: PMC6677281.

iCAD data on file. Standalone performance varies by vendor.